S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
Log in
NASDAQ:NSTG

NanoString Technologies Stock Forecast, Price & News

$70.00
-1.06 (-1.49 %)
(As of 01/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$69.26
Now: $70.00
$73.59
50-Day Range
$54.63
MA: $67.38
$73.51
52-Week Range
$13.85
Now: $70.00
$78.68
Volume581,420 shs
Average Volume743,888 shs
Market Capitalization$3.08 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.77
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and pan cancer and 360 gene expression, CAR-T characterization, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, miRNA expression, human organ transplant, human and mouse metabolic pathway, and human and mouse fibrosis panels. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq molecular profiling system to determine and analyze gene sequences within biological samples. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; Astellas Pharma, Inc.; and Oregon Health & Science University for the development of novel GeoMx® Digital Spatial Profiler protein assays to spatially profile breast cancer. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
NanoString Technologies logo

MarketRank

Overall MarketRank

1.26 out of 5 stars

Analyst Opinion: 1.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NSTG
CUSIPN/A
Phone206-378-6266
Employees551

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$125.57 million
Book Value$2.91 per share

Profitability

Net Income$-40,700,000.00

Miscellaneous

Market Cap$3.08 billion
Next Earnings Date2/24/2021 (Estimated)
OptionableOptionable
$70.00
-1.06 (-1.49 %)
(As of 01/19/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NSTG News and Ratings via Email

Sign-up to receive the latest news and ratings for NSTG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions

How has NanoString Technologies' stock price been impacted by COVID-19?

NanoString Technologies' stock was trading at $30.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NSTG shares have increased by 129.5% and is now trading at $70.00.
View which stocks have been most impacted by COVID-19
.

Is NanoString Technologies a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NanoString Technologies stock.
View analyst ratings for NanoString Technologies
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than NanoString Technologies?

Wall Street analysts have given NanoString Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but NanoString Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is NanoString Technologies' next earnings date?

NanoString Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for NanoString Technologies
.

How were NanoString Technologies' earnings last quarter?

NanoString Technologies, Inc. (NASDAQ:NSTG) announced its earnings results on Monday, November, 9th. The biotechnology company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.61) by $0.05. The biotechnology company earned $31.85 million during the quarter, compared to analyst estimates of $30.13 million. NanoString Technologies had a negative net margin of 53.47% and a negative return on equity of 68.96%.
View NanoString Technologies' earnings history
.

What price target have analysts set for NSTG?

5 equities research analysts have issued 12 month target prices for NanoString Technologies' stock. Their forecasts range from $35.00 to $75.00. On average, they anticipate NanoString Technologies' stock price to reach $55.83 in the next year. This suggests that the stock has a possible downside of 20.2%.
View analysts' price targets for NanoString Technologies
or view Wall Street analyst' top-rated stocks.

Who are some of NanoString Technologies' key competitors?

What other stocks do shareholders of NanoString Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling Co. (PD.TO) (PD), AutoZone (AZO), Designer Brands (DBI), Bank of the Ozarks (OZRK) and Vista Outdoor (VSTO).

Who are NanoString Technologies' key executives?

NanoString Technologies' management team includes the following people:
  • Mr. R. Bradley Gray, CEO, Pres & Director (Age 44, Pay $1.07M)
  • Mr. K. Thomas Bailey M.B.A., Chief Financial Officer (Age 52, Pay $589.26k)
  • Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 54, Pay $557.69k)
  • Mr. J. Chad Brown, Sr. VP of Sales & Marketing (Age 63, Pay $573.07k)
  • Dr. Joseph M. Beechem, Chief Science Officer and Sr. VP of R&D (Age 63, Pay $575.41k)
  • Mr. Mark A. Winham, Sr. VP of Operations
  • Mr. Douglas S. Farrell, VP of Investor Relations & Corp. Communications
  • Ms. Kathryn Surace-Smith, VP, Gen. Counsel & Corp. Sec. (Age 62)
  • Ms. Deborah Krogman, VP of HR
  • Dr. Mary Tedd Allen, Sr. VP of Strategic Initiatives (Age 58)

What is NanoString Technologies' stock symbol?

NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."

Who are NanoString Technologies' major shareholders?

NanoString Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Frontier Capital Management Co. LLC (0.57%), Exchange Traded Concepts LLC (0.05%) and First Hawaiian Bank (0.03%). Company insiders that own NanoString Technologies stock include Charles P Waite Jr, Charles P Waite, Jr, David W Ghesquiere, Gregory Norden, J Chad Brown, K Thomas Bailey, Kirk Malloy, Lifesciences Ii LP Clarus, Mary Tedd Allen, R Bradley Gray, Robert Hershberg and William Young.
View institutional ownership trends for NanoString Technologies
.

Which institutional investors are selling NanoString Technologies stock?

NSTG stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC. Company insiders that have sold NanoString Technologies company stock in the last year include Charles P Waite Jr, David W Ghesquiere, Gregory Norden, J Chad Brown, K Thomas Bailey, Kirk Malloy, R Bradley Gray, and Robert Hershberg.
View insider buying and selling activity for NanoString Technologies
or view top insider-selling stocks.

Which institutional investors are buying NanoString Technologies stock?

NSTG stock was purchased by a variety of institutional investors in the last quarter, including Exchange Traded Concepts LLC, and First Hawaiian Bank.
View insider buying and selling activity for NanoString Technologies
or or view top insider-buying stocks.

How do I buy shares of NanoString Technologies?

Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NanoString Technologies' stock price today?

One share of NSTG stock can currently be purchased for approximately $70.00.

How big of a company is NanoString Technologies?

NanoString Technologies has a market capitalization of $3.08 billion and generates $125.57 million in revenue each year. The biotechnology company earns $-40,700,000.00 in net income (profit) each year or ($1.93) on an earnings per share basis. NanoString Technologies employs 551 workers across the globe.

What is NanoString Technologies' official website?

The official website for NanoString Technologies is www.nanostring.com.

How can I contact NanoString Technologies?

NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at [email protected]

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.